Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Zhang H, He J, Kutateladze TG, Sakai T, Sasaki T, Markadieu N, Erneux C, Prestwich GD.
???displayArticle.abstract???
Metabolically stabilized analogues of PtdIns(3,4,5)P3 have shown long-lived agonist activity for cellular events and selective inhibition of lipid phosphatase activity. We describe an efficient asymmetric synthesis of two 5-phosphatase-resistant analogues of PtdIns(3,4,5)P3, the 5-methylene phosphonate (MP) and 5-phosphorothioate (PT). Furthermore, we illustrate the biochemical and biological activities of five stabilized PtdIns(3,4,5)P3 analogues in four contexts. First, the relative binding affinities of the 3-MP, 3-PT, 5-MP, 5-PT, and 3,4,5-PT3 analogues to the Grp1 PH domain are shown, as determined by NMR spectroscopy. Second, the enzymology of the five analogues is explored, showing the relative efficiency of inhibition of SHIP1, SHIP2, and phosphatase and tensin homologue deleted on chromosome 10 (PTEN), as well as the greatly reduced ability of these phosphatases to process these analogues as substrates as compared to PtdIns(3,4,5)P3. Third, exogenously delivered analogues severely impair complement factor C5a-mediated polarization and migration of murine neutrophils. Finally, the new analogues show long-lived agonist activity in mimicking insulin action in sodium transport in A6 cells.
Blero,
Phosphoinositide phosphatases in a network of signalling reactions.
2007, Pubmed
Blero,
Phosphoinositide phosphatases in a network of signalling reactions.
2007,
Pubmed Cantley,
Oncogenes and signal transduction.
1991,
Pubmed Drayer,
Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase.
1996,
Pubmed Erneux,
Soluble and particulate Ins(1,4,5)P3/Ins(1,3,4,5)P4 5-phosphatase in bovine brain.
1989,
Pubmed Ferguson,
Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains.
2000,
Pubmed Funamoto,
Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis.
2002,
Pubmed Hampton,
Analogs of inosine 5'-phosphate with phosphorus-nitrogen and phosphorus-sulfur bonds. Binding and kinetic studies with inosine 5'-phosphate dehydrogenase.
1969,
Pubmed Harris,
Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.
2008,
Pubmed Huang,
Stabilized phosphatidylinositol-5-phosphate analogues as ligands for the nuclear protein ING2: chemistry, biology, and molecular modeling.
2007,
Pubmed Iijima,
Tumor suppressor PTEN mediates sensing of chemoattractant gradients.
2002,
Pubmed Jia,
Inositol 1,3,4,5-tetrakisphosphate negatively regulates phosphatidylinositol-3,4,5- trisphosphate signaling in neutrophils.
2007,
Pubmed Kubiak,
Comprehensive and uniform synthesis of all naturally occurring phosphorylated phosphatidylinositols.
2003,
Pubmed Lampe,
Synthesis of selective non-Ca(2+)-mobilizing inhibitors of D-myo-inositol 1,4,5-trisphosphate 5-phosphatase.
1994,
Pubmed Lazar,
Lipid phosphatases as drug discovery targets for type 2 diabetes.
2006,
Pubmed Lietzke,
Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains.
2000,
Pubmed Maehama,
PTEN: a tumour suppressor that functions as a phospholipid phosphatase.
1999,
Pubmed Markadieu,
Phosphatidylinositol 3,4,5-trisphosphate: an early mediator of insulin-stimulated sodium transport in A6 cells.
2004,
Pubmed Murray,
Adenosine 5'-phosphorothioate. A nucleotide analog that is a substrate, competitive inhibitor, or regulator of some enzymes that interact with adenosine 5'-phosphate.
1968,
Pubmed Niggli,
Signaling to migration in neutrophils: importance of localized pathways.
2003,
Pubmed Nishio,
Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
2007,
Pubmed Ozaki,
Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers.
2000,
Pubmed Park,
Molecular control of neuronal migration.
2002,
Pubmed Pesesse,
The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
1998,
Pubmed Pesesse,
Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP.
1997,
Pubmed Pinal,
Regulated and polarized PtdIns(3,4,5)P3 accumulation is essential for apical membrane morphogenesis in photoreceptor epithelial cells.
2006,
Pubmed Prestwich,
Phosphoinositide signaling; from affinity probes to pharmaceutical targets.
2004,
Pubmed Rickert,
Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products.
2000,
Pubmed Ridley,
Cell migration: integrating signals from front to back.
2003,
Pubmed Rossier,
Epithelial sodium channels.
1994,
Pubmed Sasaki,
Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.
2000,
Pubmed Sculimbrene,
Discovery of a catalytic asymmetric phosphorylation through selection of a minimal kinase mimic: a concise total synthesis of D-myo-inositol-1-phosphate.
2001,
Pubmed Sculimbrene,
Asymmetric syntheses of phosphatidylinositol-3-phosphates with saturated and unsaturated side chains through catalytic asymmetric phosphorylation.
2004,
Pubmed Servant,
Polarization of chemoattractant receptor signaling during neutrophil chemotaxis.
2000,
Pubmed Stephens,
Roles of PI3Ks in leukocyte chemotaxis and phagocytosis.
2002,
Pubmed Sweeney,
Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes incorporation of glucose transporter 4 into the plasma membrane of muscle and fat cells without increasing glucose uptake.
2004,
Pubmed Toker,
Signalling through the lipid products of phosphoinositide-3-OH kinase.
1997,
Pubmed Traynor-Kaplan,
An inositol tetrakisphosphate-containing phospholipid in activated neutrophils.
1988,
Pubmed Vandeput,
The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
2006,
Pubmed Vanhaesebroeck,
Synthesis and function of 3-phosphorylated inositol lipids.
2001,
Pubmed Ward,
Do phosphoinositide 3-kinases direct lymphocyte navigation?
2004,
Pubmed Wymann,
Lipids on the move: phosphoinositide 3-kinases in leukocyte function.
2000,
Pubmed Xu,
Chemical synthesis and molecular recognition of phosphatase-resistant analogues of phosphatidylinositol-3-phosphate.
2006,
Pubmed Zhang,
Synthesis and biological activity of phosphatidylinositol-3,4,5-trisphosphorothioate.
2008,
Pubmed Zhang,
Synthesis and biological activity of phospholipase C-resistant analogues of phosphatidylinositol 4,5-bisphosphate.
2006,
Pubmed Zhang,
Synthesis and biological activity of PTEN-resistant analogues of phosphatidylinositol 3,4,5-trisphosphate.
2006,
Pubmed Zhang,
Synthesis and biological activity of metabolically stabilized cyclopentyl trisphosphate analogues of D-myo-Ins(1,4,5)P3.
2007,
Pubmed
